These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2847420)

  • 1. Herpes simplex virus latent infection: reactivation and elimination of latency after neurectomy.
    Tenser RB; Edris WA; Hay KA
    Virology; 1988 Nov; 167(1):302-5. PubMed ID: 2847420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation in vivo and in vitro of herpes simplex virus from mouse dorsal root ganglia which contain different levels of latency-associated transcripts.
    Ecob-Prince MS; Rixon FJ; Preston CM; Hassan K; Kennedy PG
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():995-1002. PubMed ID: 8389814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy.
    Walz MA; Price RW; Notkins AL
    Science; 1974 Jun; 184(4142):1185-7. PubMed ID: 4364361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
    Field HJ; Lay E
    Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissemination of herpes simplex virus in ganglia after footpad inoculation in neurectomized and non-neurectomized mice.
    Klein RJ; DeStefano E
    Arch Virol; 1983; 77(2-4):231-8. PubMed ID: 6314936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus.
    Al-Saadi SA; Gross P; Wildy P
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():433-8. PubMed ID: 2828517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
    Liu WG; Chen ZJ; Song JZ; Ma ZX
    Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus latency in the nervous system--a new model.
    Steiner I; Kennedy PG
    Neuropathol Appl Neurobiol; 1991 Dec; 17(6):433-40. PubMed ID: 1666173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus type 2 establishes latency in the mouse footpad and in the sensory ganglia.
    Subak-Sharpe JH; Al-Saadi SA; Clements GB
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):67s-71s. PubMed ID: 6330225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress-induced reactivation of latent herpes simplex virus infection in rat lumbar dorsal root ganglia.
    Blondeau JM; Aoki FY; Glavin GB
    J Psychosom Res; 1993 Dec; 37(8):843-9. PubMed ID: 8301624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
    Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
    J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus latency: the cellular location of virus in dorsal root ganglia and the fate of the infected cell following virus activation.
    McLennan JL; Darby G
    J Gen Virol; 1980 Dec; 51(Pt 2):233-43. PubMed ID: 6262435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of replicating herpes simplex virus in cervical dorsal root ganglia of mice following explant of individual ganglion onto susceptible indicator cells.
    Blondeau JM; Embil JA; McFarlane ES; James H; Henry M; Sangalang VE
    J Med Virol; 1986 Dec; 20(4):341-6. PubMed ID: 3025352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
    Klein RJ
    Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent stability of herpes simplex virus genomes isolated from primary and recurrent infections and dorsal root ganglia in the mouse.
    Blondeau JM; Embil JA; McFarlane ES
    J Med Microbiol; 1988 Dec; 27(4):291-6. PubMed ID: 2848947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the in vitro-reactivation of latent herpes simplex virus infection in spinal ganglia: comparison of various immune factors. Brief report.
    von Rheinbaben F; Schneweis KE
    Arch Virol; 1986; 87(3-4):315-9. PubMed ID: 2418807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced in vitro reactivation of herpes simplex virus type 2 from latently infected guinea-pig neural tissues by 5-azacytidine.
    Stephanopoulos DE; Kappes JC; Bernstein DI
    J Gen Virol; 1988 May; 69 ( Pt 5)():1079-83. PubMed ID: 2453606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and molecular aspects on herpes simplex virus latency.
    Lycke E
    Scand J Infect Dis Suppl; 1990; 69():113-9. PubMed ID: 2175937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency.
    MacLean A; Robertson L; McKay E; Brown SM
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2305-10. PubMed ID: 1654382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.